On Nov. 9, 2020, PerkinElmer announced that EUROIMMUN, a PerkinElmer company, had launched the Anti-SARS-CoV-2 QuantiVacTM ELISA (IgG) to quantify IgG antibodies against the SARS-CoV-2 S1 antigen.

The assay is available for countries accepting the CE mark, and the Company planned to file a request for this product with the U.S. FDA for Emergency Use Authorization.